Shire
Clinical trials sponsored by Shire, explained in plain language.
-
New hope for rare disease patients as treatment study begins
Disease control Recruiting nowThis study aims to learn about the safety and effects of Replagal, an enzyme replacement therapy, in Indian children and adults with Fabry disease. Participants will receive Replagal infusions every two weeks at a clinic for about one year. The research will monitor side effects …
Phase: PHASE4 • Sponsor: Shire • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
Massive global study tracks rare genetic disease over time
Knowledge-focused Recruiting nowThis study is creating a long-term registry to track people with Gaucher disease, a rare genetic condition. It follows patients over time to understand how treatments work in real life and learn about the disease's natural progression. No experimental treatments are given—patient…
Sponsor: Shire • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC